US stocks have delivered significant returns in 2026 amid heightened market volatility and shifting investor sentiment. While the Nasdaq 100 is down by 11% from its all-time highs, it is still up by 12% for the year, affirming the strong upward momentum.
The technology sector has been a key driver of market performance and sentiment, benefiting from a sustained artificial intelligence boom. Meanwhile, strong corporate earnings have also helped catapult some stocks to record highs and support broader market valuations.
However, concerns over inflation, interest rates, geopolitical tensions, and elevated valuations have contributed to periods of heightened volatility, triggering significant corrections. Heading into year-end, opportunities are increasingly cropping up amid rotation out of large artificial intelligence stocks.
Wall Street bull Dan Ives insists the recent correction fueled by AI sell off presents a golden buy opportunity just like during Covid. Explore some of the best us stocks to invest in for long term amid the recent sell off.
Stocks trading below $25 provide investors an opportunity to gain exposure to promising US companies. While a low share price does not necessarily mean a stock is undervalued, several companies trading at these levels offer compelling investment opportunities. Their long-term prospects also remain positive, supported by improving financial performance, growing businesses, attractive valuations, and long-term growth prospects.

From technology and healthcare to financial services and energy, some of these companies are benefiting from powerful industry trends that could support future earnings growth. Some of the small-cap value stocks to invest in now are trading at a discount following recent market sell-offs, potentially creating attractive entry points.
In this article, we detail some of the best US stocks to buy under $25, focusing on companies with solid fundamentals, attractive growth opportunities, and the potential to deliver meaningful long-term value.
Our Methodology
To compile our list of the 10 Best US Stocks to Buy Under $25, we looked for US companies whose revenue growth has exceeded 20% over the past 5 years. Next, we focused on the top 10 stocks most favored by institutional investors as we detailed hedge funds holding stakes in them. Finally, the 10 best US stocks to invest in for the long term were ranked in ascending order by the number of hedge funds holding stakes at the end of the second quarter.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Insider Monkey’s quarterly newsletter strategy selects 14 small-cap and large-cap stocks every quarter and has returned 612% since May 2014, beating its benchmark by 375 percentage points (see more details here).
10. First Advantage Corporation (NASDAQ:FA)
Share Price as of November 17: $21.43
Year-to-Date Gain: 49.89%
5-Year Revenue Growth: 25.33%
Number of Hedge Fund Holders: 16
First Advantage Corporation (NASDAQ:FA) is one of the best US stocks to buy under $25 as it increasingly benefits from improving demand for background screening, identity verification, and workforce-related services. The stock is up more than 40% as investors react to accelerating revenue growth, stronger earnings, and improving hiring activity.
The company’s third-quarter results were particularly encouraging, with revenue up 13.8% to $465.8 million and adjusted earnings per share up 26.7% to $0.38. The earnings improvement suggests that the company is converting its growing revenue base into stronger profitability.
Management also raised full-year revenue guidance to between $1.720 billion and $1.745 billion and expects adjusted diluted earnings per share of $1.30 to $1.33. The revised outlook signals management’s confidence that business momentum will continue through the remainder of the year. Is AI disruption a significant risk for First Advantage?
First Advantage Corporation’s integration of Sterling Check has also strengthened its long-term growth prospects. The acquisition expands its customer base, geographic reach, technology capabilities, and screening services. The company is also increasingly investing in proprietary data, automation, and artificial intelligence.
Wall Street is already taking note of First Advantage Corporation firing on all angles. On November 10, Citigroup raised the stock price target to $25 from $22 while reiterating a Neutral rating.
9. ImmunityBio, Inc. (NASDAQ:IBRX)
Share Price as of November 17: $5.98
Year-to-Date Gain: 196.04%
5-Year Revenue Growth: 299.74%
Number of Hedge Fund Holders: 27
ImmunityBio, Inc. (NASDAQ:IBRX) is one of the best US stocks to buy under $25 for investors seeking exposure to the rapidly growing biotechnology and cancer-immunotherapy industry. The stock has rallied about 200% as investors react to optimism about the company’s cancer immunotherapy drug ANKTIVA.
ANKTIVA net product revenue rose 53% in the third quarter to $48.7 million, driven by continued adoption in the US and strong market uptake. Net product revenue was up 92% for the first nine months of the year to $143.6 million, affirming the company’s transition from clinical development to commercial revenue generation.
ImmunityBio, Inc. has already received a significant boost from the FDA, expanding ANKTIVA’s approval to cover additional patients with BCG-unresponsive non-muscle-invasive bladder cancer (NMIBC). The approval expands the company’s target base and is expected to strengthen commercial opportunities. In addition, the company is pursuing growth opportunities in Europe and other international markets to expand its commercial reach. What’s up with $5.8B cancer market opportunity for ImmunityBio?
The company is also staring at additional clinical and regulatory catalysts after Cohort A in its randomized QUILT-2.005 trial met its primary endpoint. Further regulatory approvals could expand the drug’s commercial potential and provide additional catalysts for the stock.
ImmunityBio, Inc. had approximately $334.3 million in cash and cash equivalents and marketable securities as of September, expected to support commercialization, clinical development, and international expansion.
Amid the solid underlying fundamentals, Jefferies raised its price target to $14 from $12 and reiterated a Buy rating on October 14. Piper Sandler also hiked its price target to $16 from $12 following the significant regulatory milestones.
8. LifeStance Health Group, Inc. (NASDAQ:LFST)
Share Price as of November 17: $14.48
Year to Date Gain: 108.05%
5-Year Revenue Growth: 30.44%
Number of Hedge Fund Holders: 34
LifeStance Health Group, Inc. (NASDAQ:LFST) has more than doubled in value year to date as investors react to improving profitability, strong revenue growth, and expanding patient volumes. Its edge as one of the best US stocks to buy under $25 aligns with the transition from a growth-focused mental healthcare provider into a business demonstrating meaningful earnings and cash-flow generation.
While LifeStance Health Group, Inc. operates a network of outpatient mental healthcare centers, it is benefiting from increasing patient visits and an expanding network of clinicians. In the third quarter, revenue increased 25% to $455.9 million, driven by a 17% increase in patient visits to 2.7 million.
Improving profitability also continues to strengthen investor’s sentiment. The company reported Q3 net income of $22.4 million, compared with just $1.1 million in the same period last year. Adjusted EBITDA increased 70% to $68.4 million as operating income climbed to $33.1 million from $7.4 million. This suggests that revenue growth is translating into stronger profitability.
Management has also raised its financial expectations, reinforcing confidence in the company’s growth trajectory. It now expects full-year revenue between $1.741 billion and $1.761 billion, with adjusted EBITDA between $242 million and $250 million. Explore 10 stocks boasting high double-digit gains.
Even with LifeStance Health Group, Inc. more than doubling in value, a Wall Street analyst insists there is room for additional growth. On November 12, JPMorgan raised its price target by $2 to $15, buoyed by the strong quarterly results. On November 11, Barclays raised its price target to $18 and maintained an Overweight rating.
7. Flywire Corporation (NASDAQ:FLYW)
Share Price as of November 17: $22.16
Year to Date Gain: 59.42%
5-Year Revenue Growth: 36.44%
Number of Hedge Fund Holders: 35
Flywire Corporation (NASDAQ:FLYW) has rallied by more than 50% year to date, underscoring why it is one of the best US stocks to buy under $25. The outperformance comes as investors increasingly recognize its position in the global digital payments market.
Flywire Corporation has evolved beyond a traditional payment processor, combining specialized payment infrastructure with industry-specific software. As a result, it is benefiting from growing cross-border payment volumes and the increasing digitization of international transactions. Can hotel payment deals justify its growth story?
It’s also experiencing robust growth as more universities, healthcare providers, travel companies, and businesses adopt its international payment solutions. Revenue in the third quarter rose 25.1% to $250.3 million, while total payment volume on the network reached $17.8 billion, up from $13.9 billion a year earlier.
Investors are also becoming optimistic about improving profitability. Adjusted EBITDA increased 39.2% to $79.5 million in Q3, considerably faster than the 25.1% revenue growth. Furthermore, its adjusted EBITDA margin expanded from 29.4% to 32.5%, demonstrating improving operating leverage.
Management expects the growth momentum to continue, having raised its full-year outlook. It now expects 25%–27% FX-neutral revenue growth excluding ancillary services and 300–360 basis points of adjusted EBITDA margin expansion.
Wall Street analysts are also echoing Flywire Corporation’s prospects, with Truist Securities increasing its price target to $23 from $19, citing the strong financial position. Earlier on November 4, Morgan Stanley raised its price target to $26 from $24 while reiterating an Overweight rating.
6. AvePoint, Inc. (NASDAQ:AVPT)
Share Price as of November 17: $16.42
Year to Date Gain: 24.21%
5-Year Revenue Growth: 22.59%
Number of Hedge Fund Holders: 37
AvePoint, Inc. (NASDAQ:AVPT) is one of the best US stocks to buy under $25 for investors seeking exposure to cloud data management and artificial intelligence (AI) adoption. The stock has rallied by more than 20% as investors take note of the growing opportunity to secure, manage, protect, and govern the data used by artificial intelligence systems.
As companies integrate AI into their operations, they face growing risks involving sensitive data exposure, regulatory compliance, unauthorized access, and inaccurate AI-generated information. AvePoint, Inc. is offering solutions that help organizations protect and recover cloud-based data, govern access to sensitive information, and govern AI agents.
Its financial performance already demonstrates the opportunity at stake, as third-quarter revenue surged 19% to $131.1 million, driven by a 26% increase in SaaS revenue to $105.5 million. ARR increased 27% year-over-year to $495.1 million, marking the second consecutive quarter of accelerating growth. Why is adjusted margin not improving ?.
AvePoint, Inc. has continued raising its financial expectations as demand for its software solutions expands. AvePoint expects full-year 2026 revenue of $511.3 million to $513.3 million and total annual recurring revenue of $524.8 million to $528.8 million.
On November 10, 2026, AvePoint announced an expanded strategic partnership with Microsoft. The partnership could help AvePoint reach more enterprise customers as Microsoft expands its AI ecosystem. The company is also expanding beyond traditional cloud backup and data protection as it begins to monetize the growing need for enterprise AI oversight.
5. Remitly Global Inc. (NASDAQ:RELY)
Share Price as of November 17: $21.93
Year-to-Date Gain: 65.89%
5-Year Revenue Growth: 44.79%
Number of Hedge Fund Holders: 38
Remitly Global Inc. (NASDAQ:RELY) stands out as one of the best US stocks to buy under $25 because of its expanding international money-transfer business, strong customer growth, and focus on shareholder value. The stock has rallied by over 70% as investors reward the company for demonstrating it can grow its international money-transfer business while generating substantially higher profits.
Remitly Global Inc. continues to benefit from growing demand for convenient, digital international money transfers, as third-quarter revenue increased 22% to $509.8 million. Send volume was up 25% to $24.4 billion as active customers increased 17% to 10.3 million.
One of the biggest catalysts behind RELY’s stock appreciation is its ability to translate revenue growth into stronger earnings. Its net income surged 665% to $67.6 million as adjusted EBITDA increased 97% to $120.8 million.
Following third-quarter results, Remitly Global Inc. raised its full-year 2026 guidance as management sees continued momentum in its business. Full-year revenue is expected to be between $1.989 billion and $1.991 billion, representing 22% year-over-year growth. Is Remitly a top stock to buy as digital payment volume surge?
Remitly Global Inc.’s board also increased its share repurchase authorization from $200 million to $500 million. This signals management’s willingness to return capital to shareholders while continuing to invest in business expansion.
4. Crescent Energy Company (NYSE:CRGY)
Share Price as of November 17: $11.56
Year to Date Gain: 35.84%
5-Year Revenue Growth: 36.54%
Number of Hedge Fund Holders: 39
Crescent Energy Company (NYSE:CRGY) is one of the best US stocks to buy under $25, as it increasingly benefits from higher oil prices and improving operating efficiencies. The 41% year-to-date rally comes on the heels of the company transforming into a larger oil and gas producer while generating substantially more cash flow.
Crescent Energy Company has benefited from improved oil realizations and increased production volumes. In the third quarter, average production increased to 328,000 barrels of oil equivalent per day (Boe/d), up from 253,000 Boe/d a year earlier. Oil revenue surged to $1.04 billion from $596.3 million a year earlier, as realized oil prices before derivatives increased to $84.52 per barrel from $63.0. Total revenues increased to $1.35 billion from $866.58 million a year earlier.
The strong financial results come on the heels of the company completing the Vital Energy acquisition, consequently expanding Permian Basin operations and increasing its production scale. The acquisition has also created opportunities to reduce costs through operational integration. Is CRGY one of Bill Miller top stock picks?
One of Crescent Energy Company’s most important growth catalysts is its planned acquisition of Eagle Ford assets from Devon Energy. The acquisition will strengthen the company’s position in the Eagle Ford and expand its production base.
On October 14, Scotiabank initiated coverage of the stock with an Outperform rating and an $18 price target. Wells Fargo also raised its price target to $20 from $19, buoyed by the proposed acquisition of Devon Energy’s Eagle Ford assets.
3. SentinelOne, Inc. (NYSE:S)
Share Price as of November 17: $21.95
Year-to-Date Gain: 49.93%
5-Year Revenue Growth: 60.83%
Number of Hedge Fund Holders: 41
SentinelOne, Inc. (NYSE:S) is up approximately 52% year-to-date, significantly outperforming the S&P 500’s roughly 10.9% gain over the same period. The outperformance reflects improving financial performance, growing demand for the company’s AI-powered cybersecurity solutions, and confidence in the company’s ability to achieve profitable growth.
The company’s cybersecurity business continues to expand, with second-quarter fiscal 2027 revenue up 21% to $292 million. Annual recurring revenue (ARR) surged 22% to $1.218 billion, with customers generating at least $100,000 in ARR increasing 13% to 1,715.
The growth demonstrates that the company continues to attract large enterprise customers and expand its subscription-based cybersecurity business.
SentinelOne, Inc.’s edge as one of the best US stocks to buy under $25 stems from improving operating profitability. In the second quarter, non-GAAP operating margin improved to 10%, up from 2% a year earlier, as operating income rose to about $30.5 million. Diluted EPS doubled to $0.08 from $0.04. The increases affirm SentinelOne’s ability to grow while controlling expenses.
While SentinelOne, Inc. trades at a premium with a forward price-to-earnings multiple of 50x and a price-to-sales multiple of 7.25x, the same reflects expectations of continued revenue growth and improving profitability. Can SentinelOne (S) Justify Its Premium?
Wall Street firms have already echoed the company’s long-term prospects. On October 23, Rosenblatt raised its price target to $28 from $25 while maintaining a Buy rating. Earlier on October 22, Wedbush had raised its price target by $2 to $27 and maintained an Outperform rating, citing the investments the company is making in next-generation AI security.
2. Permian Resources Corporation (NYSE:PR)
Share Price as of November 17: $22.31
Year to Date Gain: 54.93%
5-Year Revenue Growth: 54.23%
Number of Hedge Fund Holders: 48
Permian Resources Corporation (NYSE:PR) is one of the best US stocks to buy under $25 for investors eyeing exposure to domestic oil and natural gas production. The stock has gained more than 50% year to date, supported by strong shareholder returns and the company’s low-cost shale operations. Is the rally just getting started?
Permian Resources Corporation continues to strengthen its position in the energy sector through expanding production and operational efficiency. The company reported record production of 457,528 barrels of oil equivalent per day in the third quarter of 2026, positioning it to benefit from favorable oil prices. Management also raised its 2026 oil production outlook, targeting production of more than 200,000 barrels per day in the second half of the year.
Higher production has also translated into substantial cash generation. Permian Resources Corporation reported adjusted free cash flow of $846 million in the third quarter, highlighting its ability to capitalize on favorable commodity prices while maintaining strong operational performance.
The robust free cash flow provides the company with financial flexibility to reward shareholders through dividends and share repurchases, reduce debt, and fund additional drilling and potential acquisitions. Permian Resources currently pays a quarterly dividend of $0.16 per share, equivalent to an annualized payout of $0.64.
Meanwhile, on November 12, Wells Fargo raised its price target for the stock to $28 from $27 and reiterated an overweight rating on the company, citing its beat of Wall Street quarterly expectations.
1. Primo Brands Corporation (NYSE:PRMB)
Share Price as of November 17: $24.05
Year to Date Gain: 48.55%
5-Year Revenue Growth: 27.82%
Number of Hedge Fund Holders: 57
Primo Brands Corporation (NYSE:PRMB) is one of the best US stocks under $25 to buy for exposure to the consumer staples sector, recurring demand for bottled water, and opportunities for long-term earnings growth. The stock has been firing on all cylinders, rallying by 47% year to date and dwarfing the 25% gain for the Insider Monkey Billionaire Index.
The outperformance follows the company’s merger with Primo Water and BlueTriton Brands that resulted in a major North American branded beverage company with exposure to several bottled water categories. Likewise, the company has achieved strong operating performance, with third-quarter revenue up 3.1% to $1.82 billion and net income rising to $124.5 million from $40.5 million a year earlier, in the same quarter.
One of Primo Brands Corporation’s competitive advantages is its Direct Delivery business. The company supplies water directly to households and businesses, including large-format bottled water and water dispensers. Explore some of the best beverage stocks to buy.
Additionally, at about $23 a share, Primo Brands trades at valuation multiples that could interest investors looking for reasonably priced consumer staples stocks. It trades at a forward price-to-earnings multiple of 16x and a price-to-sales multiple of 1.29, making it highly attractive given growing earnings and merger-related efficiencies.
Additionally, Primo Brands Corporation rewards investors with passive income, as its annual dividend is about $0.48, translating to a yield of about 2%.
READ NEXT: 10 Best Mid-Cap US Stocks to Buy Now and 10 Best Low Priced Technology Stocks to Invest In





